A Multicenter, Open-Label Study to Evaluate the Long-term Safety and Efficacy of Adjunctive Brexpiprazole 2 mg Daily in Japanese Patients with Major Depressive Disorder

Authors

Katsuhiro Iba (ORCID: https://orcid.org/0000-0003-1521-9067)
Daisuke Sekine (ORCID: https://orcid.org/0000-0001-8677-3626)
Mizuki Saito (ORCID: https://orcid.org/0000-0002-9575-6817)
Masaki Kato (ORCID: https://orcid.org/0000-0001-6727-7272)
Masako Shiosakai
Yuki Shiomi (ORCID: https://orcid.org/0000-0002-2446-2205)
Kazuo Kuwahara
Yuki Shimada
Teruhiko Higuchi (ORCID: https://orcid.org/0000-0001-6074-0068)
Kazuo Aoki (ORCID: https://orcid.org/0009-0002-6635-4218)

Institutions

Otsuka (Japan) (JP)
Kansai Medical University (JP)
National Center of Neurology and Psychiatry (JP)
Japan Coal Energy Center (JP)

Publication Details

Journal: CNS Drugs
Published: 2024-10-18
DOI: https://doi.org/10.1007/s40263-024-01124-w
Citations: 2
Primary Topic: Treatment of Major Depression
Type: article
Field-Weighted Citation Impact: 0.90

Funders

Otsuka Pharmaceutical

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

A Multicenter, Open-Label Study to Evaluate the Long-term Safety and Efficacy of Adjunctive Brexpiprazole 2 mg Daily in Japanese Patients with Major Depressive Disorder

Katsuhiro Iba, Daisuke Sekine, Mizuki Saito, Masaki Kato et al.

Oct 18, 2024

2 citations

CNS Drugs

Treatment of Major Depression

0.90

article

A Multicenter, Open-Label Study to Evaluate the Long-term Safety and Efficacy of Adjunctive Brexpiprazole 2 mg Daily in Japanese Patients with Major Depressive Disorder

Katsuhiro Iba, Daisuke Sekine, Mizuki Saito, Masaki Kato, Masako Shiosakai, Yuki Shiomi, Kazuo Kuwahara, Yuki Shimada, Teruhiko Higuchi, Kazuo Aoki

October 18, 2024article en

2 citations

Abstract

No abstract available for this paper.

CNS DrugsVol. 38(12)

Otsuka (Japan) (JP), Kansai Medical University (JP), National Center of Neurology and Psychiatry (JP), Japan Coal Energy Center (JP)

Otsuka Pharmaceutical

Good health and well-being

Openalex Percentile: Top 23%

Treatment of Major Depression

0.90

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.